jnccn.org/abstract/journals/jnccn/16/12/article-p1429.xml
Preview meta tags from the jnccn.org website.
Linked Hostnames
14- 183 links tojnccn.org
- 146 links toscholar.google.com
- 108 links topubmed.ncbi.nlm.nih.gov
- 34 links towww.ncbi.nlm.nih.gov
- 2 links towww.nccn.org
- 1 link todoi.org
- 1 link toeducation.nccn.org
- 1 link tojnccn360.org
Thumbnail

Search Engine Appearance
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.
Bing
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.
DuckDuckGo
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.
General Meta Tags
87- titleNCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018 in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 12 (2018)
- Content-Typetext/html; charset=utf-8
- descriptionThe NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.
- article:authorRobert I. Haddad
- article:authorChristian Nasr
Open Graph Meta Tags
7- og:urlhttps://jnccn.org/view/journals/jnccn/16/12/article-p1429.xml
- og:site_nameJNCCN
- og:typearticle
- og:titleNCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
- og:descriptionThe NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.
Twitter Meta Tags
4- twitter:cardsummary_large_image
- twitter:site@jnccn
- twitter:titleNCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
- twitter:descriptionThe NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E–mutated anaplastic thyroid carcinoma.
Link Tags
15- alternate/newsrss
- canonicalhttps://jnccn.org/view/journals/jnccn/16/12/article-p1429.xml
- dns-prefetch//ajax.googleapis.com
- preconnect//ajax.googleapis.com
- preconnect//ajax.googleapis.com
Emails
2- [email protected]
- ?subject=Link%20to%20NCCN%20Guidelines%20Insights%3A%20Thyroid%20Carcinoma%2C%20Version%202.2018&body=https%3A%2F%2Fjnccn.org%2Fview%2Fjournals%2Fjnccn%2F16%2F12%2Farticle-p1429.xml
Links
482- http://education.nccn.org/node/84621
- http://scholar.google.com/scholar_lookup?title=A+detailed+clinicopathologic+study+of+ALK-translocated+papillary+thyroid+carcinoma&author=A+S+CW+Chou+Fraser+Toon&publication_year=2015&journal=Am+J+Surg+Pathol&volume=39&pages=652-659
- http://scholar.google.com/scholar_lookup?title=A+large+multicenter+correlation+study+of+thyroid+nodule+cytopathology+and+histopathology&author=CC+L+GC+Wang+Friedman+Kennedy&publication_year=2011&journal=Thyroid&volume=21&pages=243-251
- http://scholar.google.com/scholar_lookup?title=A+multicenter%2C+phase+II+trial+of+everolimus+in+locally+advanced+or+metastatic+thyroid+cancer+of+all+histologic+subtypes&author=SM+H+MJ+Lim+Chang+Yoon&publication_year=2013&journal=Ann+Oncol&volume=24&pages=3089-3094
- http://scholar.google.com/scholar_lookup?title=A+phase+I+study+of+cabozantinib+%28XL184%29+in+patients+with+differentiated+thyroid+cancer&author=ME+MS+J+Cabanillas+Brose+Holland&publication_year=2014&journal=Thyroid&volume=24&pages=1508-1514